Andrea Wong

Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Sung‐Bae Kim, Rebecca Dent, Seock‐Ah Im et al. · The Lancet Oncology · 2017 · 463 citations · Full text

First-line Therapy, Breast Oncology, Medicine +7

Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury

Barry W. Festoff, Syed Ameenuddin, Paul M. Arnold et al. · Journal of Neurochemistry · 2006 · 235 citations

Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer

Lillian M. Smyth, Gerald Batist, Funda Meric‐Bernstam et al. · npj Breast Cancer · 2021 · 34 citations · Full text

Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumours

Manuel Salto‐Tellez, M. E. Nga, Hwan Chour Han et al. · British Journal of Cancer · 2007 · 29 citations · Full text

Tumor Biology, Functional Significance, Gastrointestinal Oncology +14

Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma

Andrea Wong, Ross A. Soo, Jiade J. Lu et al. · Annals of Oncology · 2006 · 28 citations · Full text

Radiation Therapy, Medicine, Advanced Nasopharyngeal Carcinoma +6